NCT00000512 arm group da2f2ef87a4453d1eac8dc0d8b6263a5 [clinicaltrials_resource:NCT00000512/arm-group/da2f2ef87a4453d1eac8dc0d8b6263a5]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00000512 arm group da2f2ef87a4453d1eac8dc0d8b6263a5 [clinicaltrials_resource:NCT00000512/arm-group/da2f2ef87a4453d1eac8dc0d8b6263a5]
Bio2RDF identifier
NCT00000512/arm-group/da2f2ef87a4453d1eac8dc0d8b6263a5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 2f2ef87a4453d1eac8dc0d8b6263a5
description [clinicaltrials_vocabulary:description]
Patients assigned to conventio ...... ive lovastatin and colestipol.
identifier
clinicaltrials_resource:NCT00000512/arm-group/da2f2ef87a4453d1eac8dc0d8b6263a5
title
NCT00000512 arm group da2f2ef87a4453d1eac8dc0d8b6263a5
@en
type
label
NCT00000512 arm group da2f2ef8 ...... f2ef87a4453d1eac8dc0d8b6263a5]
@en